|
1
|
Berasain C, Perugorria MJ, Latasa MU,
Castillo J, Goñi S, Santamaría M, Prieto J and Avila MA: The
epidermal growth factor receptor: A link between inflammation and
liver cancer. Exp Biol Med (Maywood). 234:713–725. 2009. View Article : Google Scholar
|
|
2
|
Sherman M: Hepatocellular carcinoma:
Epidemiology, risk factors and screening. Semin Liver Dis.
25:143–154. 2005. View Article : Google Scholar
|
|
3
|
El-Serag HB and Rudolph KL: Hepatocellular
carcinoma: Epidemiology and molecular carcinogenesis.
Gastroenterology. 132:2557–2576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kremsdorf D, Soussan P, Paterlini-Brechot
P and Brechot C: Hepatitis B virus-related hepatocellular
carcinoma: Paradigms for viral-related human carcinogenesis.
Oncogene. 25:3823–3833. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lupberger J and Hildt E: Hepatitis B
virus-induced oncogenesis. World J Gastroenterol. 13:74–81. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Brody H: Hepatitis C. Nature. 474:S12011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gravitz L: Introduction: A smouldering
public-health crisis. Nature. 474:S2–S4. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Thomas DL: Global control of hepatitis C:
Where challenge meets opportunity. Nat Med. 19:850–858. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Moradpour D and Penin F: Hepatitis C virus
proteins: from structure to function. Curr Top Microbiol Immunol.
369:113–142. 2013.PubMed/NCBI
|
|
10
|
Zhang Y, Li RQ, Feng XD, Zhang YH and Wang
L: Down-regulation of PTEN by HCV core protein through activating
nuclear factor-κB. Int J Clin Exp Pathol. 7:7351–7359. 2014.
|
|
11
|
Watashi K and Shimotohno K: The roles of
hepatitis C virus proteins in modulation of cellular functions: A
novel action mechanism of the HCV core protein on gene regulation
by nuclear hormone receptors. Cancer Sci. 94:937–943. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Siavoshian S, Abraham JD, Kieny MP and
Schuster C: HCV core, NS3, NS5A and NS5B proteins modulate cell
proliferation independently from p53 expression in hepatocarcinoma
cell lines. Arch Virol. 149:323–336. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Farh KK, Grimson A, Jan C, Lewis BP,
Johnston WK, Lim LP, Burge CB and Bartel DP: The widespread impact
of mammalian MicroRNAs on mRNA repression and evolution. Science.
310:1817–1821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ell B and Kang Y: MicroRNAs as regulators
of bone homeostasis and bone metastasis. Bonekey Rep. 3:5492014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang S, Xie Y, Yang P, Chen P and Zhang
L: HCV core protein-induced down-regulation of microRNA-152
promoted aberrant proliferation by regulating Wnt1 in HepG2 cells.
PLoS One. 9:e817302014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
17
|
Hou T, Ou J, Zhao X, Huang X, Huang Y and
Zhang Y: MicroRNA-196a promotes cervical cancer proliferation
through the regulation of FOXO1 and p27Kip1. Br J Cancer.
110:1260–1268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Eckman MH, Talal AH, Gordon SC, Schiff E
and Sherman KE: Cost-effectiveness of screening for chronic
hepatitis C infection in the United States. Clin Infect Dis.
56:1382–1393. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Akamatsu S, Hayes CN, Tsuge M, Miki D,
Akiyama R, Abe H, Ochi H, Hiraga N, Imamura M, Takahashi S, et al:
Differences in serum microRNA profiles in hepatitis B and C virus
infection. J Infect. 70:273–287. 2015. View Article : Google Scholar
|
|
20
|
Liu CJ, Tsai MM, Tu HF, Lui MT, Cheng HW
and Lin SC: miR-196a overexpression and miR-196a2 gene polymorphism
are prognostic predictors of oral carcinomas. Ann Surg Oncol.
20(Suppl 3): S406–S414. 2013. View Article : Google Scholar
|
|
21
|
Liu P, Xin F and Ma CF: Clinical
significance of serum miR-196a in cervical intraepithelial
neoplasia and cervical cancer. Genetics and molecular research:
GMR. 14:17995–18002. 2015. View Article : Google Scholar
|
|
22
|
Li JH, Luo N, Zhong MZ, Xiao ZQ, Wang JX,
Yao XY, Peng Y and Cao J: Inhibition of microRNA-196a might reverse
cisplatin resistance of A549/DDP non-small-cell lung cancer cell
line. Tumour Biol. Sept 16–2015.Epub ahead of print.
|
|
23
|
Li SC, Shi H, Khan M, Caplin M, Meyer T,
Öberg K and Giandomenico V: Roles of miR-196a on gene regulation of
neuroendocrine tumor cells. Mol Cell Endocrinol. 412:131–139. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ge J, Chen Z, Li R, Lu T and Xiao G:
Upregulation of microRNA-196a and microRNA-196b cooperatively
correlate with aggressive progression and unfavorable prognosis in
patients with colorectal cancer. Cancer Cell Int. 14:1282014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liu XH, Lu KH, Wang KM, Sun M, Zhang EB,
Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, et al: MicroRNA-196a
promotes non-small cell lung cancer cell proliferation and invasion
through targeting HOXA5. BMC Cancer. 12:3482012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tsai MM, Wang CS, Tsai CY, Chen CY, Chi
HC, Tseng YH, Chung PJ, Lin YH, Chung IH, Chen CY and Lin KH:
MicroRNA-196a/-196b promote cell metastasis via negative regulation
of radixin in human gastric cancer. Cancer Lett. 351:222–231. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang C, Yao C, Li H, Wang G and He X:
Combined elevation of microRNA-196a and microRNA-196b in sera
predicts unfavorable prognosis in patients with osteosarcomas. Int
J Mol Sci. 15:6544–6555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liu B, Xiang Y and Zhang HS: Circulating
microRNA-196a as a candidate diagnostic biomarker for chronic
hepatitis C. Mol Med Rep. 12:105–110. 2015.PubMed/NCBI
|
|
29
|
Mukherjee A, Di Bisceglie AM and Ray RB:
Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs
the JAK/STAT signaling pathway. J Virol. 89:3356–3365. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang Y, Wang LQ, Guo QY and Shi TL:
MicroRNA-196a overexpression promotes cell proliferation and
inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway. Int J Clin
Exp Pathol. 8:2461–2472. 2015.PubMed/NCBI
|
|
31
|
Greer EL and Brunet A: FOXO transcription
factors at the interface between longevity and tumor suppression.
Oncogene. 24:7410–7425. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Calnan DR and Brunet A: The FoxO code.
Oncogene. 27:2276–2288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Myatt SS and Lam EW: The emerging roles of
forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 7:847–859.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
34
|
Paik JH, Kollipara R, Chu G, Ji H, Xiao Y,
Ding Z, Miao L, Tothova Z, Horner JW, Carrasco DR, et al: FoxOs are
lineage-restricted redundant tumor suppressors and regulate
endothelial cell homeostasis. Cell. 128:309–323. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yang XW, Shen GZ, Cao LQ, Jiang XF, Peng
HP, Shen G, Chen D and Xue P: MicroRNA-1269 promotes proliferation
in human hepatocellular carcinoma via downregulation of FOXO1. BMC
Cancer. 14:9092014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee SY, Lee GR, Woo DH, Park NH, Cha HJ,
Moon YH and Han IS: Depletion of Aurora A leads to upregulation of
FoxO1 to induce cell cycle arrest in hepatocellular carcinoma
cells. Cell Cycle. 12:67–75. 2013. View
Article : Google Scholar :
|
